ondansetron has been researched along with Dyskinesia, Medication-Induced in 7 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty patients with schizophrenia who had neuroleptic-induced tardive dyskinesia were given 12 mg/day of ondansetron for 12 weeks in an open-label study." | 5.09 | Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. ( Giladi, N; Korczyn, AD; Mosheva, T; Shabtay, H; Sirota, P, 2000) |
| "Prochlorperazine is a centrally acting dopamine receptor antagonist that is most commonly used for the treatment of nausea and vomiting." | 3.69 | Tardive dyskinesia as a result of long-term prochlorperazine use. ( Alberts, VA; Catalano, G; Poole, MA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Kwan, C | 1 |
| Lévesque, C | 1 |
| Bédard, D | 1 |
| Frouni, I | 1 |
| Yesuf, JM | 1 |
| Hamadjida, A | 1 |
| Lévesque, D | 1 |
| Clarke, PB | 1 |
| Huot, P | 1 |
| Alberts, VA | 1 |
| Catalano, G | 1 |
| Poole, MA | 1 |
| Sirota, P | 2 |
| Mosheva, T | 2 |
| Shabtay, H | 1 |
| Giladi, N | 1 |
| Korczyn, AD | 2 |
| Zullino, DF | 1 |
| Eap, CB | 1 |
| Voirol, P | 1 |
| Shabtai, H | 1 |
| Naidu, PS | 1 |
| Kulkarni, SK | 1 |
| Simpson, GM | 1 |
| Kingsbury, SJ | 1 |
1 trial available for ondansetron and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
Topics: Adult; Aged; Antipsychotic Agents; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; H | 2000 |
6 other studies available for ondansetron and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Autoradiographic labelling of 5-HT
Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Levodopa; Ondansetr | 2022 |
Tardive dyskinesia as a result of long-term prochlorperazine use.
Topics: Antiemetics; Dopamine Antagonists; Dyskinesia, Drug-Induced; Fatal Outcome; Female; Granisetron; Hum | 1996 |
Ondansetron for tardive dyskinesia.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Interactions; Dyskinesia, Drug-Induced; Human | 2001 |
Treating tardive dyskinesia with ondansetron.
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Ondansetron; Schizophrenia; Serot | 2001 |
Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug- | 2001 |
Possible duplicate publication.
Topics: Clinical Trials as Topic; Duplicate Publications as Topic; Dyskinesia, Drug-Induced; Follow-Up Studi | 2002 |